Australian Dairy Nutritionals Group (AHF) AI Stock Analysis

• Market Cap: AU$26.88M
• Dividend Yield: N/A
• Average Volume (3M): 465.88K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.37
• Revenue Growth: 13.92%
• EPS Growth: 36.28%
• Country: AU
• Employees: N/A
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): >-0.01
• Shares Outstanding: 867,208,800
• 10 Day Avg. Volume: 385,458
• 30 Day Avg. Volume: 465,878
• PEG Ratio: 0.17
• Price to Book (P/B): 1.33
• Price to Sales (P/S): 4.44
• P/FCF Ratio: -9.19
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 40 Underperform
• Price Target: AU$0.02 ▼(-40.00% Downside)
• Action: Reiterated Date: 01/10/26
• Date: Action: Reiterated 01/10/26

The score is primarily held down by weak financial performance: despite strong revenue growth, the company remains unprofitable with negative margins and cash flow challenges. Technicals also weigh on the score given a clear downtrend and negative MACD, with oversold signals providing only a modest offset. Valuation is difficult to support because the negative P/E reflects ongoing losses and there is no dividend yield data.

Positive Factors

Sustained Revenue Growth

Revenue growth of ~34.7% indicates rising demand or distribution expansion, creating a larger base to leverage fixed costs. Over 2-6 months this supports scaling potential and gives management room to focus on converting top-line momentum into operating leverage and eventual profitability.

Very Low Financial Leverage

Extremely low debt levels provide durable financial flexibility, lowering insolvency risk and preserving capacity for strategic investments or acquisitions. This capital structure supports funding operational improvements without heavy interest burdens over the medium term.

Free Cash Flow Coverage of Losses

A free cash flow-to-net-income ratio above one implies operations can generate cash despite accounting losses, reducing dependence on external financing. This structural cash generative trait can sustain operations and fund working capital while management pursues margin recovery.

Negative Factors

Persistent Unprofitability

Negative gross and net margins across reporting periods show the core business is not yet profitable. Persisting operating losses require continued cash support, constrain reinvestment, and indicate structural pricing, cost, or mix problems that must be resolved for durable shareholder value creation.

Weak Cash Generation Trend

Declining free cash flow and negative operating cash flow relative to net income point to worsening cash conversion. Over months this elevates refinancing risk, limits capital expenditures, and forces either equity/dilutive raises or cost cuts that could impair long-term growth prospects.

Negative Return on Equity

A negative ROE indicates the firm is destroying shareholder capital rather than creating it. Persistently negative ROE undermines investor confidence, makes capital allocation decisions more constrained, and hinders the company’s ability to attract long-term funding at favorable terms.

Australian Dairy Nutritionals Group Business Overview & Revenue Model

Company Description

Australian Dairy Nutritionals Group operates as an integrated producer of dairy products in Australia. The company operates through Dairy Farms and Dairy Processing segments. The Dairy Farms segment owns and operates dairy farms and dairy livestock for the production and sale of fresh raw milk for conversion to milk and milk products. The Dairy Processing segment processes and sells dairy and nutritional products to domestic and international markets. It sells its products through supermarkets, home delivery, cross border e-commerce through distribution partners, and foodservice and niche retailers. The company offers its products under the Jonesy's, Ecklin South, Camperdown Dairy, The Collective, and Future brands. Australian Dairy Nutritionals Group was incorporated in 1992 and is based in Camperdown, Australia.

How the Company Makes Money

AHF generates revenue primarily through the sale of its dairy nutritional products, including infant formula and nutritional powders, which are sold both domestically and internationally. The company has established significant partnerships with distributors and retailers, enhancing its market reach and driving sales. Key revenue streams include direct sales to consumers, bulk sales to retailers, and exports to overseas markets. Additionally, AHF may benefit from economies of scale in production and supply chain efficiencies, which contribute to its profitability. The company's commitment to quality and innovation also allows it to command premium pricing for its products, further bolstering its revenue.

Australian Dairy Nutritionals Group Financial Statement Overview

Summary

Strong latest-year revenue growth (34.74%) is outweighed by persistent unprofitability (negative gross, EBIT/EBITDA, and net margins) and weak cash generation trends (negative free cash flow growth and negative operating cash flow to net income ratio). Low leverage is a positive, but negative ROE signals poor shareholder returns.

Income Statement

The company has shown a positive revenue growth rate of 34.74% in the latest year, indicating potential recovery. However, the gross profit margin and net profit margin remain negative, reflecting ongoing challenges in profitability. The EBIT and EBITDA margins are also negative, suggesting operational inefficiencies.

Balance Sheet

The debt-to-equity ratio is low at 0.002, indicating minimal leverage, which is a positive aspect. However, the return on equity is negative, showing that the company is not generating returns for shareholders. The equity ratio is relatively stable, suggesting a solid capital structure.

Cash Flow

The company has a negative free cash flow growth rate, indicating declining cash generation capabilities. The operating cash flow to net income ratio is negative, highlighting cash flow challenges. However, the free cash flow to net income ratio is slightly above 1, suggesting some ability to cover net losses with free cash flow.

Breakdown	TTM	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021
Income Statement
Total Revenue	7.53M	7.17M	6.18M	5.86M	5.80M	21.30M
Gross Profit	-1.10M	-1.42M	-2.15M	-288.23K	-4.36M	-3.27M
EBITDA	-4.54M	-4.30M	-6.26M	-5.95M	-1.29M	-5.34M
Net Income	-4.42M	-5.21M	-7.36M	-9.16M	-4.15M	-6.40M
Balance Sheet
Total Assets	24.17M	25.09M	30.35M	36.24M	44.60M	43.11M
Cash, Cash Equivalents and Short-Term Investments	809.01K	2.69M	6.13M	2.01M	2.43M	6.23M
Total Debt	200.85K	48.45K	2.25M	1.04M	1.09M	6.49M
Total Liabilities	2.02M	1.44M	3.62M	2.72M	4.65M	9.12M
Stockholders Equity	22.31M	23.85M	26.87M	33.59M	16.05M	33.99M
Cash Flow
Free Cash Flow	-3.65M	-3.46M	-4.72M	-7.91M	-6.90M	-7.11M
Operating Cash Flow	-3.24M	-3.28M	-4.44M	-7.05M	-3.80M	-2.03M
Investing Cash Flow	-245.46K	-47.59K	6.73M	6.18M	3.10M	1.07M
Financing Cash Flow	-184.50K	-94.51K	1.80M	449.98K	-3.07M	796.49K

Australian Dairy Nutritionals Group Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.04
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:AHF, the sentiment is Positive. The current price of 0.04 is above the 20-day moving average (MA) of 0.03, above the 50-day MA of 0.03, and above the 200-day MA of 0.04, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 61.02 is Neutral, neither overbought nor oversold. The STOCH value of 58.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:AHF.

Australian Dairy Nutritionals Group Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CLV	74 Outperform	AU$131.09M	18.57	10.07%	2.19%	38.25%	361.54%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
BUB	59 Neutral	AU$107.30M	28.57	13.97%	―	28.66%	―
BGA	51 Neutral	AU$1.94B	235.21	-0.68%	1.95%	0.49%	-127.84%
NUC	45 Neutral	AU$21.17M	-4.43	-29.43%	―	102.21%	69.47%
AHF	40 Underperform	AU$26.88M	-5.25	-20.54%	―	13.92%	36.28%
NOU	40 Underperform	AU$31.87M	-0.35	―	―	1.03%	-52.56%

Australian Dairy Nutritionals Group Corporate Events

Australian Dairy Nutritionals Seeks ASX Quotation for 19.1 Million New Shares

Australian Dairy Nutritionals Limited has applied for quotation on the ASX of 19,109,443 new fully paid ordinary shares under its existing issuer code AHF. The new securities, issued on 25 February 2026 and linked to a previously announced transaction, will expand the company’s listed capital base and may influence liquidity and shareholder positioning without altering its core dairy nutrition operations.

The move reflects ongoing capital management activities as the group continues to support its dairy nutrition growth strategy within the listed market framework. By increasing the volume of quoted shares, the company may enhance trading flexibility for investors while reinforcing its presence in the Australian equity market.

The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.

Australian Dairy Nutritionals Completes Entitlement Offer, Retains Shortfall Placement Option

Australian Dairy Nutritionals Limited has completed its 1-for-6 pro rata non-renounceable entitlement offer, issuing 19,109,443 new shares and raising about $535,000 before costs, with total shares on issue increasing to 762,431,258. The company will allot and list the new shares immediately and retains the option to place the 104,777,527-share shortfall to investors within three months at no less than $0.028 per share, providing additional capital-raising flexibility that could support its operations and growth in the competitive dairy nutrition market.

The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.

Australian Dairy Nutritionals Limits $3.5m Entitlement Offer to Core Regional Investors

Australian Dairy Nutritionals Limited has launched a 1-for-6 pro rata non-renounceable entitlement offer of fully paid ordinary shares at $0.028 per share to raise approximately $3.47 million, available only to shareholders with registered addresses in Australia, China, Hong Kong, and New Zealand who meet relevant securities law criteria. The company has formally notified overseas investors outside these jurisdictions that they are ineligible to participate due to the cost and complexity of complying with additional regulatory regimes, and because the potential capital from those holders would be relatively small; as the offer is non-renounceable, those ineligible shareholders will not receive any payment or value for the entitlements they would otherwise have received, effectively concentrating the capital-raising opportunity among its core regional investor base.

The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.

Australian Dairy Nutritionals Launches A$3.47m Entitlement Offer at Discounted Issue Price

Australian Dairy Nutritionals Limited has launched a 1-for-6 pro rata non-renounceable entitlement offer to raise approximately A$3.47 million through the issue of new fully paid ordinary shares at A$0.028 per share to eligible shareholders on the 30 January 2026 record date. The new shares, which will rank equally with existing stock, are available to investors in Australia, China, Hong Kong and New Zealand, with the retail offer open from 4 to 18 February 2026 and the company warning that shareholders who do not participate may face dilution while those who do can also apply for additional shares subject to any shortfall, potentially widening the register and strengthening the group’s capital position.

The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.

Australian Dairy Nutritionals Launches $3.5m Entitlement Offer With Limits on Control Shift

Australian Dairy Nutritionals Limited has launched a 1-for-6 pro rata non-renounceable entitlement offer of fully paid ordinary shares at $0.028 per share to raise approximately $3.47 million. Eligible shareholders on the 30 January 2026 record date can subscribe for new shares and apply for additional shares under a top-up facility, with the company outlining that full take-up would leave control unchanged, while non-participating holders face potential dilution of up to about 14.3%. The board has committed to ensuring no investor’s holding exceeds 19.99% through the allocation of additional shares and any required pro rata scale-back, and expects that no shareholder will hold 20% or more on completion of the offer, limiting any significant change in control dynamics.

The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.

Australian Dairy Nutritionals Plans Large Pro Rata Share Issue

Australian Dairy Nutritionals Limited has announced a proposed non-renounceable pro rata issue of up to 123,886,970 fully paid ordinary shares, with an ex-date of 29 January 2026, a record date of 30 January 2026, and an expected issue date of 25 February 2026. The capital raising will expand the company’s equity base and could provide additional funding flexibility for its dairy nutrition operations, with implications for existing shareholders’ holdings through dilution but also potential support for future growth initiatives and balance sheet strength.

The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.

Australian Dairy Nutritionals Launches A$3.47m Entitlement Offer to Fund China Growth and Efficiency Upgrades

Australian Dairy Nutritionals Limited has launched a pro-rata non-renounceable entitlement offer to raise approximately A$3.47 million by issuing up to 123.9 million new shares at A$0.028 each, allowing eligible shareholders in Australia, New Zealand, Hong Kong and China to subscribe for one new share for every six held. The capital raising, which includes a top-up facility and potential placement of any shortfall at the board’s discretion, is aimed at funding capital equipment to improve processing efficiency, supporting the company’s growth strategy in China, and providing additional working capital, underscoring a push to accelerate expansion in 2026 while prioritising participation by existing shareholders.

The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.

Australian Dairy Nutritionals Shares Halted Pending Material Capital Raising

Australian Dairy Nutritionals Limited has requested and been granted a trading halt on its securities on the ASX while it prepares an announcement regarding a proposed capital raising. The company has indicated that the capital raising will be material to its operations, with trading expected to resume by 27 January 2026 or upon release of the funding details, signaling a potentially significant move to strengthen its balance sheet or support future growth initiatives.

The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.

Australian Dairy Nutritionals Boosts China Powder Sales but Vietnam Setback Drags Quarterly Revenue

Australian Dairy Nutritionals Group reported Q2 FY26 consolidated revenue of $1.4 million, with nutritional powder sales of $776,000 up 152% on the prior corresponding period, driven by expanded distribution of its Future brand in China and contract packing. Overall quarterly revenue was down 19% year-on-year due to stock returns following unexpected regulatory and packaging changes in Vietnam and lower milk and livestock sales after exiting the North Brucknell farm lease, although first-half FY26 revenue remains 15% ahead of the prior year. The company posted operating cash outflows of $1.11 million for the quarter and finished with $809,000 in cash after the expiry of a $1.22 million funding facility, leaving it without that secured line, while directors’ remuneration remained steady at $80,000. Management is banking on continued distribution growth of the Future brand via China’s o2o M2C global shopping app, with presence now in seven provinces and a target of 1,000 active stores by the end of FY26, alongside the anticipated resumption of shipments to Vietnam once revised packaging is in place, to accelerate revenue growth in the second half and underpin its positioning in Asian nutritional powder markets.

The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.